FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a conformationally restricted cyclic oligopeptide producing two stable and specific epitopes each of which is able to react with a target ligand, to a pharmaceutical composition comprising the above oligopeptide, and to a method for producing the oligopeptide.
EFFECT: producing the conformationally restricted cyclic oligopeptide.
19 cl, 8 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EPITOPES FORMED BY NONCOVALENT BINDING CONJUGATES | 2000 |
|
RU2259194C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER | 2011 |
|
RU2595389C2 |
| BETA-AMYLOID ANTIBODIES | 2013 |
|
RU2689674C2 |
| PEPTIDES-DERIVATIVES IL-4 FOR MODULATION OF CHRONIC INFLAMMATORY RESPONSE AND TREATMENT OF AUTOIMMUNE DISEASES | 2009 |
|
RU2542375C2 |
| ANTIBODY TO AMYLOID BETA | 2013 |
|
RU2651486C2 |
| IMMUNOGENIC POLYPEPTIDE COMPOSITION, METHOD OF COMPOSITION PREPARING, METHOD OF PRODUCING AND METHOD OF ANTIBODY DETECTION, SET | 1992 |
|
RU2136311C1 |
| NEW BINDING MOLECULES WITH ANTI-TUMOUR ACTIVITY | 2013 |
|
RU2627185C1 |
| MONOMETHYLVALINE COMPOUNDS CAPABLE OF FORMING CONJUGATES WITH LIGANDS | 2004 |
|
RU2448117C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMOUR | 2011 |
|
RU2636461C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF TUMOUR | 2010 |
|
RU2563359C2 |
